FY2025 EPS Estimate for PTC Therapeutics Lifted by Analyst
PTC Therapeutics, Inc. (NASDAQ:PTCT – Free Report) – Analysts at Cantor Fitzgerald upped their FY2025 earnings per share (EPS) estimates for shares of PTC Therapeutics in a research report issued to clients and investors on Tuesday, March 4th. Cantor Fitzgerald analyst K. Kluska now expects that the biopharmaceutical company will post earnings per share of […]
PTC Therapeutics, Inc. (NASDAQ:PTCT – Free Report) – Analysts at Cantor Fitzgerald upped their FY2025 earnings per share (EPS) estimates for shares of PTC Therapeutics in a research report issued to clients and investors on Tuesday, March 4th. Cantor Fitzgerald analyst K. Kluska now expects that the biopharmaceutical company will post earnings per share of […]
